NM_000257.4(MYH7):c.2221G>A (p.Gly741Arg) AND Cardiomyopathy
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Apr 7, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001170500.3
Allele description [Variation Report for NM_000257.4(MYH7):c.2221G>A (p.Gly741Arg)]
NM_000257.4(MYH7):c.2221G>A (p.Gly741Arg)
Condition(s)
- Name:
- Cardiomyopathy (CMYO)
- Synonyms:
- Cardiomyopathies
- Identifiers:
- MONDO: MONDO:0004994; MedGen: C0878544; Human Phenotype Ontology: HP:0001638
-
equilibrative nucleoside transporter 1 isoform 3 [Homo sapiens]
equilibrative nucleoside transporter 1 isoform 3 [Homo sapiens]gi|751130520|ref|NP_001291394.1|Protein
-
(("clinical guidelines"[Resource Type]) OR "practice guideline"[P... (28)
(("clinical guidelines"[Resource Type]) OR "practice guideline"[Publication Type]) AND ("Dehiscence of surgical wound")SearchBooks
-
Saccharomyces cerevisiae strain XL3-1 RNA polymerase II largest subunit (RPB1) g...
Saccharomyces cerevisiae strain XL3-1 RNA polymerase II largest subunit (RPB1) gene, partial cdsgi|380875946|gb|JQ287810.1|Nucleotide
-
Microbe sample from Actinobacillus pleuropneumoniae
Microbe sample from Actinobacillus pleuropneumoniaebiosample
-
Sample from Mus musculus
Sample from Mus musculusbiosample
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: May 12, 2024